A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action

in Vaccines and Molecular Therapeutics

• Sabine Arve-Butler
• Cody Deumont Moorman

Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: a systematic review

in Vaccines and Molecular Therapeutics

• Takele Adugna
• Qingli Niu
• Guiquan Guan
• Junzheng Du
• Jifei Yang
• Zhancheng Tian
• Hong Yin

Development of a two-component recombinant vaccine for COVID-19

in Vaccines and Molecular Therapeutics

• Yi-Sheng Sun
• Fang Xu
• Han-Ping Zhu
• Yong Xia
• Qiao-Min Li
• Yuan-Yuan Luo
• Hang-Jing Lu
• Bei-Bei Wu
• Zhen Wang
• Ping-Ping Yao

Association of the immunogenicity of intramuscular SARS-CoV-2 mRNA vaccination with computed tomography muscle images in patients with muscular disorders

in Vaccines and Molecular Therapeutics

• Tomoaki Naka
• Michinori Funato
• Kunihiko Yasuda
• Takahiro Nakayama
• Satoshi Kuru

MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity

in Vaccines and Molecular Therapeutics

• Ilka Grewe
• Monika Friedrich
• Marie-Louise Dieck
• Michael Spohn
• My Linh Ly
• Verena Krähling
• Leonie Mayer
• Sibylle C. Mellinghoff
• Monika Rottstegge
• Rebekka Kraemer

SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy

in Vaccines and Molecular Therapeutics

• Ioana Martac
• Sina A. Beer
• Aileen Schenk
• Osama Ahmad
• Claus-Philipp Maier
• Gülay Demirel
• Beate Preuß
• Reinhild Klein
• Anna M. P. Stanger
• Britta Besemer

Revitalizing Tetanus Vaccine Literacy Post Road Accidents: A Comprehensive Examination of Knowledge and Awareness Initiative among Non-Medical University Students in Lahore, Pakistan

in Vaccines and Molecular Therapeutics

Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children

in Vaccines and Molecular Therapeutics

• Youjia Zhong
• Amuthavalli Kottaiswamy
• Chen Xiang Ang
• Hui’ En Li
• Gaik Chin Yap
• Carina J. X. Tay
• Nurul Elyana Osman
• Siti Namirah Binte Roslan
• Chee Wah Tan
• Wee Chee Yap

Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: A multicentre, prospective, longitudinal cohort study

in Vaccines and Molecular Therapeutics

• Junhong Xu
• Youhua Yuan
• Guohua Chen
• Bin Ma
• Yinlong Zou
• Baoya Wang
• Wenjuan Yan
• Qi Zhang
• Qiong Ma
• Xiaohuan Mao

Comprehensive analyses of immune activity in COVID-19-vaccinated Idiopathic Pulmonary Fibrosis patients

in Vaccines and Molecular Therapeutics

• Agata Maciejewska
• Piotr Czernia
• Magdalena Piotrowska-Mieczkowska
• Beata Wajda
• Bartosz Słomiński
• Jan Romantowski
• Adam Sudoł
• Małgorzata Dąbrowska
• Lucyna Górska
• Tomasz Smiatacz

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization

in Vaccines and Molecular Therapeutics

• William R. Lykins
• Jeroen Pollet
• Jessica A. White
• Brian Keegan
• Leroy Versteeg
• Ulrich Strych
• Wen-Hsiang Chen
• Raodoh Mohamath
• Gabi Ramer-Denisoff
• Sierra Reed

Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production

in Vaccines and Molecular Therapeutics

• Beatriz Castro-Robles
• Francisco J Cimas
• Lourdes Arias-Salazar
• JESUS ONTAÑON
• Julia Lozano
• Susana López-López
• Fernando Andrés-Pretel
• María Ángeles Requena-Calleja
• Antonio Mas
• Gemma Serrano-Heras